An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy. [electronic resource]
Producer: 20011204Description: 111-6 p. digitalISSN:- 0009-9104
- AIDS-Related Opportunistic Infections -- blood
- Adult
- Antigens, Viral -- immunology
- Antiretroviral Therapy, Highly Active
- Biomarkers -- blood
- Cells, Cultured
- Cohort Studies
- Cytomegalovirus -- immunology
- Cytomegalovirus Retinitis -- blood
- Dipeptidyl Peptidase 4 -- blood
- Female
- HIV -- genetics
- HIV Infections -- blood
- Humans
- Interferon-gamma -- biosynthesis
- Ki-1 Antigen -- blood
- Male
- Middle Aged
- RNA, Viral -- blood
- Th1 Cells -- enzymology
- Th2 Cells -- enzymology
- Viral Load
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.